Ex Parte LEVEILLE - Page 10


               Appeal No. 2000-1862                                                                                                   
               Application 08/834,061                                                                                                 

               article that is “for” or “capable” of use in a particular type of apparatus to perform a method with                   
               that apparatus.7  Cf. Loctite Corp. v. Ultraseal, Ltd., 781 F.2d 861, 868, 228 USPQ 90, 94 (Fed.                       
               Cir. 1985), overruled on other grounds, Nobelpharma AB v. Implant Innovations, 141 F.3d 1059,                          
               1068, 46 USPQ2d 1097, 1104 (Fed. Cir. 1998) (The claim language “adapted to remain in a                                
               liquid, nonpolymerizing state for prolonged periods of time while in contact with air and to                           
               polymerize to the solid state in the absence of air and upon contact with metal surfaces . . .” was                    
               interpreted by the court “as merely language of intended use, not a claim limitation. [Citation                        
               omitted; emphasis supplied.]”); In re Pearson, 494 F.2d 1399, 1402-03, 181 USPQ 641, 644                               
               (CCPA 1974) (The claim language “for reducing pops and unsound kernels in peanut plants . . .                          
               [and] when applied to the foliage of a peanut crop will substantially reduce the formation of pops                     
               and unsound kernels” was held by the court to “merely set forth the intended use, or a property                        
               inherent in, an otherwise old composition. [Emphasis supplied.]”); Wiggins, 397 F.2d at 357-59,                        
               158 USPQ at 200-01 (The independent product claim recited “[a] pharmaceutical preparation in                           
               dosage unit form adapted for administration to obtain an analgesic effect,” and the court stated                       
               that “[w]ere the [reference] to describe or render obvious such a composition, . . . that                              
               composition, of course, would not appear to differ in any material manner from the composition                         
               of appellant’s claim, no matter to what ultimate use it would be put. [Footnote omitted; emphasis                      
               supplied.]”).                                                                                                          
                       In comparing the claimed rare earth-doped sol-gel glass monolith product as                                    
               encompassed by appealed claims 37, 3, 5 and 7, as we have interpreted these claims above, with                         
               the disclosure of Orignac, we find that, as a matter of fact, the examiner has established a prima                     
               facie case of anticipation under § 102(a) by pointing out where each and every element of the                          
               claimed invention, arranged as required by the claim, is described identically in the reference                        

                                                                                                                                     
               7  Indeed, if the limitation was given effect as limiting the claims to encompassing the described                     
               product only in the stated use environment of calibrating the specified type of optical instrument,                    
               such that the same product in another use environment would not be encompassed by the                                  
               appealed claims as appellant argues, then the appealed claims would be substantial duplicates of                       
               the method claims which are said by counsel at oral hearing to be of record in continuation                            
               application 09/599,231 and have been allowed by the examiner, and would be considered by the                           
               examiner on that basis.                                                                                                

                                                                - 10 -                                                                



Page:  Previous  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  Next 

Last modified: November 3, 2007